Understanding basic steps to hematopoietic stem cell transplantation evaluation
- PMID: 23675562
- PMCID: PMC3649815
Understanding basic steps to hematopoietic stem cell transplantation evaluation
Abstract
We are celebrating one millionth transplant in year 2013! With continued improvement in hematopoietic cell transplantation (HCT) outcome, the indications for HCT continue to grow. Furthermore the sources of stem cells and the number of suitable matches are expanding. At the same time, modified transplantation regimens have facilitated safer procedures despite increase in patient's age and comorbidies. In the current era, any patient indicated for HCT has a stem cell source and therefore steps to HCT and coordinated pre-transplant care is an integral part of management to improve transplant outcome. This review discusses our approach to the transplant evaluation process and this article will serve as a valuable tool for primary care physicians and referring hematologists/oncologists.
Keywords: Transplantation; evaluation; hematological malignancies; preparation.
Similar articles
-
Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.Dan Med Bull. 2007 May;54(2):112-39. Dan Med Bull. 2007. PMID: 17521527 Review.
-
Indications and outcomes of reduced-toxicity hematopoietic stem cell transplantation in adult patients with hematological malignancies.Int J Hematol. 2013 May;97(5):581-98. doi: 10.1007/s12185-013-1313-0. Epub 2013 Apr 13. Int J Hematol. 2013. PMID: 23585244 Review.
-
Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.Biol Blood Marrow Transplant. 2015 Nov;21(11):1863-1869. doi: 10.1016/j.bbmt.2015.07.032. Epub 2015 Aug 7. Biol Blood Marrow Transplant. 2015. PMID: 26256941 Free PMC article.
-
What the internist should know about stem cell transplant in the elderly patient.Eur J Intern Med. 2018 Dec;58:43-47. doi: 10.1016/j.ejim.2018.06.018. Epub 2018 Jun 28. Eur J Intern Med. 2018. PMID: 29960832 Review.
-
The Glasgow Prognostic Score as a pre-transplant risk assessment for allogeneic hematopoietic cell transplantation.Clin Transplant. 2017 Nov;31(11). doi: 10.1111/ctr.13103. Epub 2017 Oct 22. Clin Transplant. 2017. PMID: 28871665
Cited by
-
The effect of pre-transplant pain and chronic disease self-efficacy on quality of life domains in the year following hematopoietic stem cell transplantation.Support Care Cancer. 2018 Apr;26(4):1243-1252. doi: 10.1007/s00520-017-3947-6. Epub 2017 Nov 9. Support Care Cancer. 2018. PMID: 29124418 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10–29. - PubMed
-
- Thomas ED. A history of bone marrow transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Thomas’ Hematopoietic Cell Transplantation. West Sussex, UK: Wiley-Blackwell; 2009. pp. 3–7.
-
- Horowitz MM. Uses and growth of hematopoietic cell transplantation. In: Appelbaum FR, Forman SJ, Negrin RS, Blume KG, editors. Thomas’ Hematopoietic Cell Transplantation. West Sussex, UK: Wiley-Blackwell; 2009. pp. 15–21.
-
- Pasquini MC, Wang Z. Current use and outcome of hematopoietic stem cell transplantation:CIBMTR Summary Slides. 2010 at: http://www.cibmtr.org. http://www.cibmtr.org.
-
- Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Van Lint MT, Wingard JR, Tichelli A. Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant. 2012;47:337–341. - PMC - PubMed
LinkOut - more resources
Full Text Sources